Literature DB >> 16258159

An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene.

Alessandro Saluto1, Alessandro Brussino, Flora Tassone, Carlo Arduino, Claudia Cagnoli, Patrizia Pappi, Paul Hagerman, Nicola Migone, Alfredo Brusco.   

Abstract

Several diagnostic strategies have been applied to the detection of FMR1 gene repeat expansions in fragile X syndrome. Here, we report a novel polymerase chain reaction-based strategy using the Expand Long Template PCR System (Roche Diagnostics, Mannheim, Germany) and the osmolyte betaine. Repeat expansions up to approximately 330 CGGs in males and up to at least approximately 160 CGGs in carrier women could be easily visualized on ethidium bromide agarose gels. We also demonstrated that fluorescence analysis of polymerase chain reaction products was a reliable tool to verify the presence of premutation and full mutation alleles both in males and in females. This technique, primarily designed to detect premutation alleles, can be used as a routine first screen for expanded FMR1 alleles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258159      PMCID: PMC1867559          DOI: 10.1016/S1525-1578(10)60594-6

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  21 in total

Review 1.  Premature ovarian failure and the FMR1 gene.

Authors:  A Murray
Journal:  Semin Reprod Med       Date:  2000       Impact factor: 1.303

2.  Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?

Authors:  S L Sherman
Journal:  Am J Hum Genet       Date:  2000-06-12       Impact factor: 11.025

3.  No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers.

Authors:  A Murray; S Ennis; N Morton
Journal:  Am J Hum Genet       Date:  2000-07       Impact factor: 11.025

4.  Standardization of PCR amplification for fragile X trinucleotide repeat measurements.

Authors:  C D O'Connell; D H Atha; J P Jakupciak; J A Amos; K l Richie
Journal:  Clin Genet       Date:  2002-01       Impact factor: 4.438

5.  FXTAS, SCA10, and SCA17 in American patients with movement disorders.

Authors:  Ana I Seixas; Martin H Maurer; Mark Lin; Colleen Callahan; Alka Ahuja; Tohru Matsuura; Christopher A Ross; Fuki M Hisama; Isabel Silveira; Russell L Margolis
Journal:  Am J Med Genet A       Date:  2005-07-01       Impact factor: 2.802

6.  Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus.

Authors:  C Houdayer; A Lemonnier; M Gerard; C Chauve; M Tredano; T B de Villemeur; P Aymard; J P Bonnefont; D Feldmann
Journal:  Clin Chem Lab Med       Date:  1999-04       Impact factor: 3.694

7.  Automated Detection of Trinucleotide Repeats in Fragile X Syndrome.

Authors: 
Journal:  Mol Diagn       Date:  1997-12

8.  FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia.

Authors:  A Brussino; C Gellera; A Saluto; C Mariotti; C Arduino; B Castellotti; M Camerlingo; V de Angelis; L Orsi; P Tosca; N Migone; F Taroni; A Brusco
Journal:  Neurology       Date:  2005-01-11       Impact factor: 9.910

9.  A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males.

Authors:  L A Haddad; R C Mingroni-Netto; A M Vianna-Morgante; S D Pena
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

10.  Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen A Leehey; Deborah A Hall; Richard A Levine; James A Brunberg; Lin Zhang; Tristan Jardini; Louise W Gane; Susan W Harris; Kristin Herman; James Grigsby; Claudia M Greco; Elizabeth Berry-Kravis; Flora Tassone; Paul J Hagerman
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

View more
  52 in total

1.  Sleep apnea in fragile X premutation carriers with and without FXTAS.

Authors:  Alyssa Hamlin; Ying Liu; Danh V Nguyen; Flora Tassone; Lin Zhang; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-09-19       Impact factor: 3.568

Review 2.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

3.  You can build it ... but will they come?: the potential "expansion" of testing methodologies for fragile X syndrome.

Authors:  Nicholas T Potter
Journal:  J Mol Diagn       Date:  2009-05-21       Impact factor: 5.568

4.  FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Authors:  Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M Ignacia Peña; Isabel Salas; M Angélica Alliende
Journal:  Genet Res (Camb)       Date:  2016-06-28       Impact factor: 1.588

Review 5.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

6.  Emotion potentiated startle in fragile X syndrome.

Authors:  Elizabeth C Ballinger; Lisa Cordeiro; Alyssa D Chavez; Randi J Hagerman; David Hessl
Journal:  J Autism Dev Disord       Date:  2014-10

7.  Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene.

Authors:  Eric D Dodds; Flora Tassone; Paul J Hagerman; Carlito B Lebrilla
Journal:  Anal Chem       Date:  2009-07-01       Impact factor: 6.986

8.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

9.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

10.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.